What are Catalyst Pharmaceutical's profit margins?

Catalyst Pharmaceutical (CPRX) runs a 86.0% gross margin and a 44.8% operating margin, with a 37.1% net margin.

Where do Catalyst Pharmaceutical's ratios come from?

Every ratio is computed from Catalyst Pharmaceutical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Catalyst Pharmaceutical CPRX Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Gross margin	85.2%-0.8pp	86%-1.0pp	86.9%+3.0pp	83.9%-0.5pp
Operating margin	43.8%+4.1pp	39.7%+17.9pp	21.8%-25.7pp	47.5%+10.3pp
Net margin	36.4%+3.1pp	33.3%+15.4pp	17.9%-20.9pp	38.8%+10.8pp
Returns
Return on equity	25.5%-3.9pp	29.4%+8.6pp	20.7%-12.0pp	32.8%+11.8pp
Return on invested capital	84.5%+21.2pp	63.3%+12.8pp	50.5%-305pp	355.1%+256pp
Efficiency
Asset turnover	0.6×-0.1×	0.7×-0.2×	0.9×+0.2×	0.7×0.0×
Liquidity
Current ratio	6.1×+0.9×	5.2×+2.3×	2.9×-2.7×	5.6×-2.2×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Net debt / EBITDA	-2.4×-0.2×	-2.2×-1.1×	-1.1×+1.8×	-2.9×+0.3×
Per Share
Book value per share	$7.50+28.8%	$5.82+70.8%	$3.41+26.4%	$2.70+40.6%
Valuation
Market capitalization	$2.87B+15.2%	$2.49B+38.9%	$1.79B-7.4%	$1.94B+177%
Price / earnings	13.4×-1.8×	15.2×-9.9×	25.1×+1.8×	23.3×+5.6×
Price / sales	4.9×-0.2×	5.1×+0.6×	4.5×-4.5×	9×+4.1×
Price / book	3×-0.4×	3.4×-1.2×	4.6×-1.8×	6.4×+3.1×
EV / EBITDA	7.3×-1.2×	8.5×-5.4×	13.9×-2.2×	16×+5.9×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Catalyst Pharmaceutical.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Catalyst Pharmaceutical's profit margins?: Catalyst Pharmaceutical (CPRX) runs a 86.0% gross margin and a 44.8% operating margin, with a 37.1% net margin.
Where do Catalyst Pharmaceutical's ratios come from?: Every ratio is computed from Catalyst Pharmaceutical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.